about
Intranasal sumatriptan for migraine in children.Amine oxidases and monooxygenases in the in vivo metabolism of xenobiotic amines in humans: has the involvement of amine oxidases been neglected?Factors and Mechanisms for Pharmacokinetic Differences between Pediatric Population and AdultsGastric stasis in migraineurs: etiology, characteristics, and clinical and therapeutic implications.Sumatriptan succinate : pharmacokinetics of different formulations in clinical practice.Sumatriptan transdermal iontophoretic patch (NP101-Zelrix™): review of pharmacology, clinical efficacy, and safety in the acute treatment of migraineBreath powered nasal delivery: a new route to rapid headache relief.Drugs targeting 5-hydroxytryptamine receptors in acute treatments of migraine attacks. A review of new drugs and new administration forms of established drugs.Sumatriptan iontophoretic transdermal system for the acute treatment of migraine.A novel intranasal breath-powered delivery system for sumatriptan: a review of technology and clinical application of the investigational product AVP-825 in the treatment of migraine.The iontophoretic transdermal system formulation of sumatriptan as a new option in the acute treatment of migraine: a perspective.Population Pharmacokinetic Analysis of Zolmitriptan and Its Metabolite in Adults and Adolescents to Support Dose Selection in Children With Migraine.A sumatriptan iontophoretic transdermal system for the acute treatment of migraine.Twelve-month tolerability and efficacy study of NP101, the sumatriptan iontophoretic transdermal system.AVP-825: a novel intranasal delivery system for low-dose sumatriptan powder in the treatment of acute migraine.Preliminary brain-targeting studies on intranasal mucoadhesive microemulsions of sumatriptan.Correlation between nasal membrane permeability and nasal absorption rate.Rapid absorption of sumatriptan powder and effects on glyceryl trinitrate model of headache following intranasal delivery using a novel bi-directional device.Pharmacokinetics of sumatriptan nasal spray in children.Randomized, double-blind, placebo-controlled, parallel-group, multi-center study of the safety and efficacy of ADAM zolmitriptan for the acute treatment of migraine.Le sumatriptan intranasal pour la migraine chez les enfants.Intranasal mucoadhesive microemulsions of zolmitriptan: preliminary studies on brain-targeting.Pharmacokinetic Characterization and Dose Selection of a Novel Sumatriptan Nasal Spray Formulation, DFN-02.Breath-powered sumatriptan dry nasal powder: an intranasal medication delivery system for acute treatment of migraine.Enhanced pharmacological efficacy of sumatriptan due to modification of its physicochemical properties by inclusion in selected cyclodextrins
P2860
Q35601543-55D9BCF9-37C6-4576-A7D5-795C5E1B2B0FQ36941961-FAAE5B5D-C826-4BE6-92AF-2475CCB6C6AEQ37378093-C9EA309A-005A-4A5C-89DA-AD9CB9D340B4Q37398431-B2D2436E-F51F-419B-BD1F-6ABD7F5721BFQ38046616-6404CDE4-6419-4F69-9318-BA4AC8AD420BQ38051308-EA7CC0C0-B9DB-4B37-8CB2-F1937511CDE0Q38136260-D9E51473-D227-4900-A5F3-18F8F3BB0168Q38167355-6AEF9857-EA3A-4D3E-8583-F9FF1B96B0EEQ38196927-633367FF-386E-4713-96D7-444F3CF1161AQ38539637-990F8342-AA56-4190-8539-45029D4AF2CAQ38542062-854CCAE2-A063-462D-9CAB-68D4F543C239Q38674724-E4A0015A-DF5F-44DA-BFFD-2DE0ECBBDDC1Q39246366-B565C4AA-3642-49A8-9C53-B200803757BEQ39251453-0A8989EF-46DD-4707-9BB6-9D2D5AA2C0FFQ39366862-AE40760A-0B89-4569-942C-89FFEF45BDD4Q41831096-5E6A0E05-D4A8-4242-A9E4-5654D7F9EC3DQ42926999-74BB8BB4-994B-456C-B043-2B039E7D8390Q43286999-18DEF313-7D6A-452D-856A-19F6ED91E056Q44820355-2F8B181D-9F93-420D-BF59-765FD3A6E9D7Q46377572-1C539F32-A6BE-467F-94BF-D8E4FA5863F3Q46651593-FCF2287F-EA1F-4747-8030-53FB3788F0DBQ46731832-8A0195B1-4A1C-4D73-8602-6D03E9C83978Q48301256-79B6FF5D-27C8-4D1A-A578-A85F4C7EFC2FQ54920214-7E71556B-09F0-4957-8D5D-9EF42A3507A2Q58577471-20429740-D057-4280-9BE6-3B8D61613B23
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Clinical pharmacokinetics of intranasal sumatriptan.
@ast
Clinical pharmacokinetics of intranasal sumatriptan.
@en
Clinical pharmacokinetics of intranasal sumatriptan.
@nl
type
label
Clinical pharmacokinetics of intranasal sumatriptan.
@ast
Clinical pharmacokinetics of intranasal sumatriptan.
@en
Clinical pharmacokinetics of intranasal sumatriptan.
@nl
prefLabel
Clinical pharmacokinetics of intranasal sumatriptan.
@ast
Clinical pharmacokinetics of intranasal sumatriptan.
@en
Clinical pharmacokinetics of intranasal sumatriptan.
@nl
P2093
P1476
Clinical pharmacokinetics of intranasal sumatriptan
@en
P2093
Andrew Barrow
Eliane Fuseau
Katy H P Moore
Olivier Petricoul
P304
P356
10.2165/00003088-200241110-00002
P50
P577
2002-01-01T00:00:00Z
P6179
1023323823